[AMRS] Amyris, Inc.

Overview

Type of security: Stock

Sector: Basic Industries

Industry: Major Chemicals

Market Capitalization: 84.47 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.71 Change: 0.03 (4.28%)
Ext. hours: 0.7 Change: -0.01 (-1.22%)

chart AMRS

Refresh chart

Strongest Trends Summary For AMRS

AMRS is in the medium-term down -28% below S&P in 1 month. In the long-term down -45% below S&P in 2 years and down -100% below S&P in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Amyris, Inc., a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. It builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The company produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the production and commercialization of diesel and jet fuels. The company was former

Fundamental Ratios
Shares Outstanding211.17 M EPS-6.31 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -15.42% Sales Growth - Q/Q-32.05% P/E-0.48
P/E To EPS Growth P/S1.87 P/BV-0.46 Price/Cash Per Share1.86
Price/Free Cash Flow-0.94 ROA-34.92% ROE36.34% ROI-54.44%
Current Ratio1.34 Quick Ratio1.12 Long Term Debt/Equity17.06 Debt Ratio-0.28
Gross Margin21.8% Operating Margin-217.94% Net Profit Margin-149.48% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities7.32 M Cash From Investing Activities-1.07 M Cash From Operating Activities-3.28 M Gross Profit1.23 M
Net Profit-52.24 M Operating Profit-25.16 M Total Assets193.05 M Total Current Assets69.3 M
Total Current Liabilities51.65 M Total Debt242.99 M Total Liabilities378.61 M Total Revenue7.87 M
Technical Data
High 52 week9.2 Low 52 week1.88 Last close3.46 Last change-1.98%
RSI14.05 Average true range0.36 Beta1.28 Volume768.67 K
Simple moving average 20 days-18.92% Simple moving average 50 days-15.69% Simple moving average 200 days-10.71%
Performance Data
Performance Week-13.5% Performance Month-27.77% Performance Quart17.29% Performance Half-12.41%
Performance Year-55.06% Performance Year-to-date3.59% Volatility daily3.72% Volatility weekly8.33%
Volatility monthly17.06% Volatility yearly59.1% Relative Volume154.97% Average Volume936.44 K
New High New Low

News

2019-11-15 16:07:00 | Amyris Closes on Exchange to Resolve CVI Heights Debt

2019-11-11 08:30:00 | Amyris Executes Agreements to Resolve CVI Heights Debt

2019-11-08 02:45:07 | Edited Transcript of AMRS earnings conference call or presentation 7-Nov-19 9:30pm GMT

2019-11-07 16:05:00 | Amyris Continues to Deliver Strong Revenue Growth

2019-10-24 09:01:00 | Haeggquist & Eck, LLP Investigates Amyris Officers and Directors Regarding Restatement of Financial Results

2019-10-23 08:30:00 | Amyris to Announce Third Quarter Financial Results on Thursday, November 7, 2019

2019-10-18 16:40:00 | WeissLaw LLP: Amyris, Inc. is the Subject of a Legal Investigation

2019-10-10 08:00:00 | Amyris Pipette Brand Successfully Launches on Amazon.com

2019-10-07 14:30:00 | Amyris Files Form 10-Qs to Achieve Compliance - Notes Receipt of Nasdaq Deficiency Notification

2019-10-04 09:10:42 | Edited Transcript of AMRS earnings conference call or presentation 2-Oct-19 8:30pm GMT

2019-10-03 08:30:00 | Biossance Introduces The Clean Academy

2019-10-01 09:23:00 | Amyris Provides Highlights of First Half 2019 Financial Results

2019-09-27 08:30:00 | Amyris to Host First-Half 2019 Financial Results Teleconference on Wednesday, October 2, 2019

2019-09-26 09:47:00 | Scott+Scott Attorneys at Law LLP Continues to Investigate Amyris, Inc.’s Directors and Officers for Breach of Fiduciary Duty – AMRS

2019-09-20 08:49:00 | Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 3, 2019

2019-09-16 08:30:00 | Clean Beauty Leader Biossance Enters the Australian and New Zealand Markets

2019-09-12 15:23:11 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-09-10 15:45:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-09-09 14:35:00 | Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - NASDAQ: AMRS

2019-09-05 16:42:54 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-09-04 08:30:00 | Amyris Launches Pipette, a Clean Baby Care Brand Delivering a Critical Need for a Growing Market

2019-09-02 07:02:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-08-30 08:30:00 | Amyris to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019

2019-08-28 10:00:00 | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amyris, Inc. AMRS

2019-08-27 14:37:00 | Meet 3 Companies that Are Shaping the Future of Food

2019-08-27 10:08:00 | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amyris, Inc. AMRS

2019-08-26 17:35:41 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-08-22 16:44:00 | Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

2019-08-22 11:41:00 | Scott+Scott Attorneys at Law LLP Continues Investigation into Amyris, Inc.’s Directors and Officers for Breach of Fiduciary Duty – NASDAQ: AMRS

2019-08-08 09:04:34 | Lavvan Appoints Former MedReleaf CEO Neil Closner To Its C-Suite

2019-08-08 09:00:00 | LAVVAN Appoints Neil Closner as Chief Executive Officer

2019-07-26 08:30:00 | Amyris to Host Business Update Teleconference and Webcast on Monday, August 5, 2019

2019-07-19 08:30:00 | ADL Bionatur Solutions and Amyris Expand Contract to 2020

2019-07-12 08:56:00 | Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference

2019-06-27 21:30:00 | Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm

2019-06-27 08:30:00 | Jonathan Van Ness Joins BIOSSANCE as First Celebrity Ambassador

2019-06-10 08:00:00 | Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains

2019-06-04 16:07:00 | Amyris Appoints Kathleen Valiasek Chief Business Officer-Appoints Jonathan Wolter as Interim CFO

2019-06-03 15:00:00 | AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Deadline

2019-06-03 10:49:14 | DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-06-03 10:32:00 | AMRS & CRCM -Deadline Alert - Bronstein, Gewirtz & Grossman, LLC

2019-06-02 23:42:44 | AMYRIS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Amyris, Inc. - AMRS

2019-06-02 20:34:00 | FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm

2019-06-01 09:05:00 | Will Amyris Wisely Return Its Focus to Consumer Brands?

2019-05-31 22:50:00 | AMYRIS 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against Amyris, Inc. - AMRS

2019-05-31 16:02:38 | Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.

2019-05-31 13:20:00 | IMPORTANT JUNE 3 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2019-05-30 18:48:00 | KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for AMYRIS, INC. Investors – AMRS

2019-05-30 17:40:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS

2019-05-30 15:05:44 | AMYRIS MONDAY DEADLINE: Rosen, a Top Ranked Law Firm, Reminds Investors of Amyris, Inc. of Important June 3rd Deadline in Securities Class Action – AMRS